ETV4 immunohistostaining is a sensitive and specific diagnostic biomarker for CIC-rearranged sarcoma of the central nervous system

Histopathology. 2022 Dec;81(6):852-855. doi: 10.1111/his.14796. Epub 2022 Oct 4.

Chloé Ouvrard¹, Alice Métais^{1

2

3}, Enola Brigot¹, Charlotte Berthaud¹, Noémie Pucelle¹, Joëlle Lacombe¹, Lauren Hasty¹, Fabrice Chrétien^{1

2}, Franck Bielle⁴, Karima Mokhtari⁴, Dominique Cazals-Hatem⁵, Benoît Lhermitte⁶, Emmanuelle Uro-Coste^{7

8

9}, Pascale Varlet^{1

2

3}, Arnault Tauziède-Espariat^{1

2

3}; RENOCLIP-LOC

¹ Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France.
² Université de Paris, Paris, France.
³ Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR S1266, INSERM, IMA-BRAIN, Paris, France.
⁴ ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neuropathologie, F-75013, Sorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute, Paris, France.
⁵ Department of Pathology, APHP University Hospital Beaujon, Clichy, France.
⁶ Department of Pathology, Strasbourg Hospital, Strasbourg, France.
⁷ Department of Pathology, Toulouse University Hospital, Toulouse, France.
⁸ INSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
⁹ Université Paul Sabatier, Toulouse, France.

No abstract available

Publication types